Navigation Links
FDA Advisory Committee Recommends Approval of ACTEMRA(R) (tocilizumab) for the Treatment of Rheumatoid Arthritis
Date:7/29/2008

body and is a natural substance that can raise inflammation. Everyone has IL-6 in their body, but people with RA may have too much. If approved, ACTEMRA will be the first and only medication to specifically target IL-6 in patients with RA.

About Rheumatoid Arthritis

Rheumatoid arthritis is a progressive, systemic autoimmune disease characterized by inflammation of the membrane lining in the joints. This inflammation causes a loss of joint shape and function, resulting in pain, stiffness and swelling, ultimately leading to irreversible joint destruction and disability. Characteristics of RA include redness, swelling, pain and movement limitation around joints of the hands, feet, elbows, knees and neck that leads to loss of function. In addition, the systemic symptoms of RA include fatigue, decreased hemoglobin, osteoporosis and may contribute to shortening life expectancy by affecting major organ systems. After 10 years, less than 50 percent of patients can continue to work or function normally on a daily basis. RA affects more than 21 million people worldwide with approximately 1.3 million adults affected in the United States.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by Med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a Top Company for Older Workers (AARP) and one of the Best Companies to Work For in America (Fortune). For additional information
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
2. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
3. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
4. Patient Safety Authority Board of Directors Names Infection Advisory Panel
5. Broker a Suite of Research & Advisory Services to Enhance Human Resources
6. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
7. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
8. Delta Dental Plans Association Forms National Scientific Advisory Committee
9. Alter+Care Creates the Advisory Board
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... New York, NY (PRWEB) March 26, 2015 ... year to raise awareness of Parkinson’s disease and funds ... (APDA) purpose to Ease the Burden – Find the ... for registration and will take place in more than ... Phoenix, Rhode Island, New Jersey, San Antonio, Minnesota, Seattle, ...
(Date:3/26/2015)... 2015 In preparation for the 2016 ... founded by Samir Becic, has issued “report cards” ... health and fitness, as well as their promotion of ... includes Sen. Ted Cruz, who has officially announced his ... other politicians who have shown interest in running for ...
(Date:3/26/2015)... CT (PRWEB) March 26, 2015 CRN ... State Capitol Building to help celebrate the achievement of ... groundbreaking employment program serving some 500 people. , The ... The WorkPlace in partnership with the Connecticut ... and prepare long-term unemployed workers and place them at ...
(Date:3/26/2015)... Los Lunas, N.M., resident Lyndsi Alderete never ... year, when she attended a pageant and had an ... a debilitating disease of the lungs that affects the ... failure. The disease turned the Alderete’s world upside down ... pageant to raise awareness about her daughter’s disease. ...
(Date:3/26/2015)... 26, 2015 The beauty industry united ... a man who revolutionized the business of beauty education. ... Passage; founder of Pivot Point International, Inc. Passage’s wife ... of Leo. Held at the Art Institute of Chicago, ... of industry and media leaders and served as the ...
Breaking Medicine News(10 mins):Health News:American Parkinson Disease Association 2015 Optimism Walk Season Launches Nationwide 2Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 2Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 3Health News:CRN International Shows Support For Groundbreaking Connecticut Program To Aid The Unemployed 2Health News:Albuquerque Area Mom Enters Mrs. New Mexico Pageant to Help Fight Pulmonary Hypertension 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 3
... Point Action Plan on infectious waste control during a ... Monday,s Washington Times (link below), Emergency Preparedness ... issues, such as SARS, have highlighted the vulnerability our ... the area of operational sustainability in a crisis. ...
... Increase in Free Water ClearanceTOKYO and PRINCETON, N.J., ... and Otsuka Pharmaceutical Development and Commercialization, Inc. (OPDC) ... Administration (FDA) has approved SAMSCA(TM) (tolvaptan) as the ... of patients with clinically significant hypervolemic and euvolemic ...
... Experiences of Denton Regional ... DALLAS, May 21 T-System, Inc., the leading provider of ... care centers, today announced that its Emergency Department Information System ... entitled "ED Information Systems: A Guideline For Successful Implementation" in ...
... the region,s most prominent business organization, today applauded Governor ... report in Atlanta, Georgia. Greater Baltimore Committee President ... process has been of great value to the bioscience ... appreciated by the business community. He is the ...
... 17 states have won awards in the "Fight the Bite" ... Prevention and the DEET Education Program. Started in 2007, ... that encourage children and adults to protect against mosquito and ... of the winning posters are at www.fightthebitecontest.org ...
... May 21 For the second year in a row, ... donate blood through the Red Cross by joining Red ... Cross Racing is a program designed to increase the ... donate. Participants of this program can get points for a ...
Cached Medicine News:Health News:Coalition Calls on Secretary of Health to Make Hospital Emergency Preparedness a Priority 2Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 2Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 3Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 4Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 5Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 6Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 7Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 8Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 9Health News:The T SystemEV(R) Featured in Journal of Emergency Nursing Paper on Successful EDIS Implementation 2Health News:The T SystemEV(R) Featured in Journal of Emergency Nursing Paper on Successful EDIS Implementation 3Health News:'Fight the Bite' Poster Contest Honors 28 Students in 17 States 2Health News:'Fight the Bite' Poster Contest Honors 28 Students in 17 States 3Health News:NASCAR Fans Boost Blood Donations; The American Red Cross Joins 3M and Greg Biffle to Kick off Season Two 2Health News:NASCAR Fans Boost Blood Donations; The American Red Cross Joins 3M and Greg Biffle to Kick off Season Two 3
(Date:3/26/2015)... LAKES, N.J. , March 26, 2015  Becton, ... today that it will commence offers to exchange all ... issued by CareFusion Corporation, a wholly owned subsidiary of ... described in the table below. A Registration Statement on ... of the New Notes was filed with the Securities ...
(Date:3/26/2015)... BUENA, N.J. , March 26, 2015 ... New Jersey based specialty generic pharmaceutical company, ... drug application (ANDA) to the U.S. Food and Drug ... number of ANDA submissions now pending at the FDA ... and CEO of the Company, commented, "On March 2, ...
(Date:3/26/2015)... 2015  Imagine a loved relative suffering from cancer ... the drugs are too expensive. The Austrian Centre of ... to reduce production costs of highly valued drugs significantly. ... the mercy of pathogens or cancer cells. Therapeutic antibodies ... for controlling autoimmune diseases such as multiple sclerosis. According ...
Breaking Medicine Technology:Becton, Dickinson and Company to Commence Exchange Offers 2Becton, Dickinson and Company to Commence Exchange Offers 3Becton, Dickinson and Company to Commence Exchange Offers 4Becton, Dickinson and Company to Commence Exchange Offers 5IGI Laboratories, Inc. Announces First ANDA Submission Of 2015 2World's First Method for Continuous Purification of Valuable Antibodies 2
... Alternatives International, Inc. ("NAI") (NASDAQ: NAII ), ... supplements, announced today that on February 6 it filed ... Inc. in U.S. District Court for the District of ... 8,067,381 ("the ,381 patent"), entitled "Methods and compositions for ...
... Feb. 14, 2012  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... call and live webcast on Monday, February 27, 2011 at ... will provide a business update and review fourth quarter and ... and press release may be accessed from the Investors section ...
Cached Medicine Technology:Natural Alternatives International, Inc. Files Patent Infringement Claim Against DNP International Co., Inc. 2Natural Alternatives International, Inc. Files Patent Infringement Claim Against DNP International Co., Inc. 3
... German Craftsmanship have produced the ... world. Ocutek® now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
... of German Craftsmanship have produced ... the world. Ocutek now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
Vertical punch designed to create a 1.5mm clean cylindrical hole. Rotatable for convenient positioning. Flat Handle. Overall length 87mm....
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
Medicine Products: